Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

A Brunet1, A Bonni, M J Zigmond

  • 1Children's Hospital and Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Cell
|April 2, 1999
PubMed

Insights

Survival factors prevent cell death by regulating the transcription factor FKHRL1. Akt phosphorylation keeps FKHRL1 in the cytoplasm, but its absence triggers nuclear entry and apoptosis.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Biochemistry

Background:

  • Survival factors inhibit apoptosis through Akt activation, phosphorylating BAD and Caspase 9.
  • The serine/threonine kinase Akt plays a crucial role in cell survival pathways.
  • Apoptosis, or programmed cell death, is a tightly regulated cellular process.

Purpose of the Study:

  • To investigate the role of Akt in regulating the Forkhead transcription factor FKHRL1.
  • To elucidate the mechanism by which survival factors influence FKHRL1 activity and localization.
  • To determine FKHRL1's contribution to apoptosis induction.

Main Methods:

  • Western blotting to detect protein phosphorylation.
  • Immunoprecipitation to study protein-protein interactions (Akt, FKHRL1, 14-3-3 proteins).
  • Subcellular fractionation to determine FKHRL1 localization (cytoplasmic vs. nuclear).
  • Quantitative PCR and reporter assays to assess target gene expression.

Main Results:

  • Akt phosphorylates FKHRL1 in the presence of survival factors.
  • Phosphorylated FKHRL1 binds to 14-3-3 proteins and remains in the cytoplasm.
  • Survival factor withdrawal causes FKHRL1 dephosphorylation, nuclear translocation, and activation of target genes.
  • FKHRL1 nuclear translocation is associated with the induction of apoptosis, including Fas ligand expression.

Conclusions:

  • Akt-mediated phosphorylation of FKHRL1 is a key mechanism for survival factor-mediated suppression of apoptosis.
  • FKHRL1 acts as a pro-apoptotic transcription factor upon nuclear translocation.
  • This pathway highlights a novel regulatory axis controlling cell fate decisions.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...